Thomas M. Ross - Feb 1, 2023 Form 4 Insider Report for MAXCYTE, INC. (MXCT)

Role
EVP, Global Sales & Marketing
Signature
/s/ Brian F. Leaf, Attorney-in-Fact
Stock symbol
MXCT
Transactions as of
Feb 1, 2023
Transactions value $
-$106,975
Form type
4
Date filed
2/3/2023, 03:32 PM
Previous filing
Jan 5, 2023
Next filing
Mar 21, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MXCT Common Stock Options Exercise $2.43K +2.47K $0.98 2.47K Feb 1, 2023 Direct F1
transaction MXCT Common Stock Options Exercise $32.3K +15.1K +611.43% $2.14 17.6K Feb 1, 2023 Direct F1
transaction MXCT Common Stock Sale -$99.7K -17.6K -100% $5.68 0 Feb 1, 2023 Direct F1, F2
transaction MXCT Common Stock Options Exercise $24.8K +11.6K $2.14 11.6K Feb 2, 2023 Direct F1
transaction MXCT Common Stock Sale -$66.8K -11.6K -100% $5.77 0 Feb 2, 2023 Direct F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MXCT Employee Stock Option (right to buy) Options Exercise $0 -2.47K -100% $0.00* 0 Feb 1, 2023 Common Stock 2.47K $0.98 Direct F1, F4
transaction MXCT Employee Stock Option (right to buy) Options Exercise $0 -15.1K -15.27% $0.00 83.7K Feb 1, 2023 Common Stock 15.1K $2.14 Direct F1, F5
transaction MXCT Employee Stock Option (right to buy) Options Exercise $0 -11.6K -13.83% $0.00 72.1K Feb 2, 2023 Common Stock 11.6K $2.14 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2022.
F2 The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.51 to $5.86, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.69 to $5.87, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 This option is fully vested and exercisable.
F5 The shares underlying this option vested or shall vest monthly in forty-eight (48) equal monthly installments commencing on April 4, 2019, subject to the Reporting Person's continued service to the Issuer through each vesting date.